Core Viewpoint - The company has successfully met the conditions for the first unlock period of its 2023 restricted stock incentive plan, allowing 35 eligible participants to unlock a total of 3.558 million shares, representing approximately 0.0957% of the company's total share capital, with the unlock date set for October 17, 2025 [2][12]. Summary by Sections Incentive Plan Details - The 2023 restricted stock incentive plan has undergone necessary approval processes, including board and supervisory committee meetings, with independent directors providing opinions and the supervisory committee verifying the plan [2][3]. - The plan's first unlock period conditions have been met, allowing for the release of shares for 35 participants [7][11]. Share Unlocking Process - The company held a series of meetings to approve the unlocking of shares, with the first unlock period for the reserved grant set to expire on August 25, 2025 [7][12]. - The total number of shares eligible for unlocking is 3.558 million, with the unlock date confirmed as October 17, 2025 [12]. Adjustments to the Incentive Plan - Adjustments were made to the number of participants and shares due to changes in eligibility, resulting in a reduction of the total number of restricted shares from 13 million to 12.97 million [8][9]. - The company has also planned to repurchase and cancel shares from participants who no longer meet the eligibility criteria, totaling 940.60 thousand shares, which is 0.25% of the total share capital [9][10]. Future Actions - The company will continue to monitor and adjust the incentive plan as necessary, with further meetings scheduled to address any additional changes or repurchases of restricted shares [10][11].

有效期、限售及解除限售安排 本激励计划首次授予的第一类限制性股票有效期最长不超过60个月，限售期分别为自首次授予登记完成 之日起12个月、24个月、36个月。解除限售期分三个阶段，首个解除限售期为首次授予登记完成之日起 12个月后的首个交易日起至24个月内的最后一个交易日当日止，解除限售比例为40%，后续两个阶段分 别为30%。 解除限售考核要求公司层面业绩考核：以2025 - 2027年为考核年度，设定收入和净利润双指标。收入指 标方面，2025年目标值18亿元，触发值16亿元；2026年目标值20亿元，触发值17亿元；2027年目标值23 亿元，触发值19亿元。净利润指标方面，2025年比2024年净利润增加1.00亿元，2026年增加1.70亿元， 2027年增加2.40亿元。两个指标分开计算，达成情况对应不同解除限售比例。个人层面绩效考核：结果 分为"A、B、C、D"四个档次，对应个人层面可解除限售比例分别为100%、100%、70%、0%。 2025年10月15日，深圳市智动力（维权）精密技术股份有限公司发布公告，宣布2025年限制性股票激励 计划第一类限制性股票首次授予登记工作已完成，相关股票于当 ...

Core Points - Lens Technology (300433)(06613) announced that on October 15, 2025, it will transfer 18.2304 million shares from inventory due to the vesting of restricted stock under the 2023 restricted stock incentive plan [1] Company Summary - The company is executing a restricted stock incentive plan, which involves the transfer of a significant number of shares [1] - The specific number of shares being transferred is 18.2304 million, indicating a substantial impact on the company's stock structure [1] - The vesting date for these shares is set for October 15, 2025, suggesting a long-term incentive strategy aimed at aligning employee interests with company performance [1] Industry Summary - The announcement reflects ongoing trends in the technology sector regarding employee compensation and retention strategies through stock incentives [1] - Such incentive plans are common in the industry, aiming to motivate employees and enhance productivity by tying their compensation to company performance [1] - The transfer of shares may influence market perceptions and investor sentiment towards the company, particularly in relation to its growth and employee engagement strategies [1]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：000963 证券简称：华东医药 公告编号：2025-090 华东医药股份有限公司 第十一届董事会第三次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 一、董事会会议召开情况 华东医药股份有限公司（以下简称"公司"）第十一届董事会第三次会议的通知于2025年10月10日以书面 和电子邮件等方式送达各位董事，于2025年10月13日（星期一）在公司会议室以现场并结合通讯方式召 开。会议应参加董事11名，实际参加董事11名。会议由公司董事长主持。会议的召开和表决程序符合 《公司法》《公司章程》的有关规定，会议合法有效。 二、董事会会议审议情况 董事会就以下议案进行了审议，经书面和通讯方式表决，通过决议如下： 审议通过《关于2022年限制性股票激励计划预留授予限制性股票第二个解除限售期解除限售条件成就的 议案》 具体内容详见公司同日披露于巨潮资讯网（http://www.cninfo.com.cn）的公司《关于2022年限制性股票 激励计划预留授予限制性股票第二个解除限售期解除限售条件成就的公 ...

Core Viewpoint - The company has announced the public disclosure of the list of incentive objects for the 2025 Restricted Stock Incentive Plan, confirming compliance with relevant regulations and the absence of objections during the public notice period [1][2][4][8]. Group 1: Public Disclosure of Incentive Plan - The company held a board meeting on September 19, 2025, to approve the draft of the 2025 Restricted Stock Incentive Plan [1][10]. - The public notice period for the incentive objects was from September 30, 2025, to October 14, 2025 [3]. - The public notice was conducted internally, allowing employees to provide feedback through various channels, with no objections received [4][5]. Group 2: Verification of Incentive Objects - The board's remuneration and assessment committee verified the list of incentive objects against their qualifications, ensuring compliance with the management regulations and listing rules [5][6]. - The incentive objects include core management personnel and key staff, excluding directors, senior management, and significant shareholders [7][8]. - The committee confirmed that the basic information of the incentive objects is accurate and meets the conditions set forth in the management regulations [7][8]. Group 3: Insider Information Compliance - The company conducted a self-inspection regarding insider trading by individuals with knowledge of the incentive plan, confirming no trading activities occurred during the specified period [10][11]. - All insider information handlers were registered, and confidentiality measures were implemented to prevent information leakage [12]. - The self-inspection concluded that there were no violations of insider trading regulations related to the incentive plan [12].

登录新浪财经APP 搜索【信披】查看更多考评等级 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 一、董事会会议召开情况 宁夏东方钽业股份有限公司第九届董事会第二十四次会议通知于2025年9月30日以电子邮件、短信的形 式向各位董事发出。会议于2025年10月13日在东方钽业办公楼二楼会议室以现场表决和通讯表决相结合 的方式召开，应出席会议董事8人，实出席会议董事8人。公司部分高管人员列席了本次会议。会议的召 集、召开符合《公司法》《公司章程》的规定。会议由董事长黄志学先生主持。 二、董事会会议审议情况 1、以7票同意，0票反对，0票弃权（黄志学董事为本次限制性股票激励计划的激励对象，对本议案回避 表决），审议通过了《关于2022年限制性股票激励计划预留授予部分第一个解除限售期解除限售条件成 就的议案》。 具体内容详见2025年10月14日《证券时报》《证券日报》《中国证券报》《上海证券报》和巨潮资讯网 www.cninfo.com.cn《关于2022年限制性股票激励计划预留授予部分第一个解除限售期解除限售条件成 就的公告》。 2、以8票同意，0票反对，0票弃 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002331 证券简称：皖通科技 公告编号：2025-051 安徽皖通科技股份有限公司（以下简称"公司"）第六届董事会第三十八次会议于2025年10月13日以通讯 表决方式在公司会议室召开。本次临时会议的通知及会议资料已于2025年10月10日以电子邮件形式送达 各位董事。本次会议应到董事9人，实到董事9人，会议由公司董事长陈翔炜先生主持，公司部分高级管 理人员列席了本次会议。本次会议符合法律法规及《公司章程》的有关规定。 二、董事会会议审议情况 审议通过《关于为控股子公司申请银行综合授信提供担保的议案》 本议案同意9票，反对0票，弃权0票。 《安徽皖通科技股份有限公司关于为控股子公司申请银行综合授信提供担保的公告》刊登于2025年10月 14日《证券时报》《中国证券报》和巨潮资讯网（http://www.cninfo.com.cn）。 特此公告。 安徽皖通科技股份有限公司 安徽皖通科技股份有限公司 第六届董事会第三十八次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 一、董事会会议召开 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：688116 证券简称：天奈科技 公告编号：2025-077 转债代码：118005 债券简称：天奈转债 江苏天奈科技股份有限公司 关于2022年限制性股票激励计划首次授予部分 第三个归属期归属结果暨股份上市的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ● 本次股票上市类型为股权激励股份；股票认购方式为网下，上市股数为100,240股。 本次股票上市流通总数为100,240股。 ● 本次股票上市流通日期为2025年10月16日。 根据中国证券监督管理委员会、上海证券交易所、中国证券登记结算有限责任公司上海分公司有关业务 规则的规定，江苏天奈科技股份有限公司（以下简称"公司"）收到中国证券登记结算有限责任公司上海 分公司于2025年10月10日出具的《证券变更登记证明》，公司已完成2022年限制性股票激励计划（以下 简称"2022年激励计划"）首次授予部分第三个归属期的股份登记工作。现将有关情况公告如下： 一、激励计划已履行的决策程序和信息 ...

Core Points - The announcement details the first vesting results of the 2024 restricted stock incentive plan for Wuhan Changying Tong Optoelectronic Technology Co., Ltd. [1] - A total of 905,141 shares will be listed for trading on October 17, 2025, as part of the stock incentive plan [2][3] Group 1: Stock Incentive Plan Details - The stock type for this listing is equity incentive shares, with a total of 905,141 shares available for trading [2] - The decision-making process for the stock vesting was approved during the board meeting on July 17, 2024, where several related proposals were discussed and passed [3][4] - The company conducted an internal announcement regarding the incentive plan participants from July 18 to July 27, 2024, with no objections received [5] Group 2: Vesting and Stock Source - The number of shares vesting in this round is 905,141, with 75 individuals qualifying as incentive recipients [12][13] - The shares for this vesting come from the company's repurchase of its A-share common stock from the secondary market [11][15] Group 3: Trading Restrictions and Capital Changes - There are restrictions on the transfer of shares for directors and senior management, including a limit of 25% of their total holdings per year during their tenure [13][14] - The total share capital of the company remains unchanged as the shares are sourced from repurchased stock, and the controlling shareholder's stake is unaffected [15] Group 4: Verification and Registration - The verification report by Zhonghuan Accounting Firm confirmed that the company received a total of RMB 10,255,247.53 from the incentive recipients as of September 4, 2025 [16] - The registration of the shares for the first vesting period was completed on October 10, 2025, with the relevant proof issued by the Shanghai branch of China Securities Depository and Clearing Corporation [16]

Core Points - Helenzheng announced the completion of the 2024 annual profit distribution on June 26, 2025 [2] - The company held the 15th meeting of the 6th Board of Directors and the 11th meeting of the 6th Supervisory Board on October 13, 2025 [2] - The company adjusted the grant price of the 2023 restricted stock incentive plan from 1.93 yuan per share to 1.90 yuan per share [2]